Biomarker Analysis of First-Line Sintilimab Plus Gemcitabine and Cisplatin in Patients with Advanced Biliary Tract Cancers: Results from a Phase II Study.
Journal of clinical oncology（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined